0002042684-24-000001.txt : 20241104 0002042684-24-000001.hdr.sgml : 20241104 20241104133027 ACCESSION NUMBER: 0002042684-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241104 DATE AS OF CHANGE: 20241104 EFFECTIVENESS DATE: 20241104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Onconaut Therapeutics, Inc. CENTRAL INDEX KEY: 0002042684 ORGANIZATION NAME: IRS NUMBER: 920270877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-528575 FILM NUMBER: 241422216 BUSINESS ADDRESS: STREET 1: 27604 E. EUCLID DRIVE CITY: AURORA STATE: CO ZIP: 80016 BUSINESS PHONE: (000) 000-0000 MAIL ADDRESS: STREET 1: 27604 E. EUCLID DRIVE CITY: AURORA STATE: CO ZIP: 80016 D 1 primary_doc.xml X0708 D LIVE 0002042684 Onconaut Therapeutics, Inc. 27604 E. EUCLID DRIVE AURORA CO COLORADO 80016 (000) 000-0000 DELAWARE None None Corporation true 2022 Daniel V. LaBarbera c/o Onconaut Therapeutics Inc. 27604 E. Euclid Drive Aurora CO COLORADO 80016 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2024-10-21 false true true Promissory note convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion false 0 125000 125000 0 false 1 0 0 0 false Onconaut Therapeutics, Inc. /s/ Daniel V. LaBarbera Daniel V. LaBarbera Chief Executive Officer 2024-11-04